Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Integral Diagnostics Ltd

Healthcare AU IDX

2.04AUD
0.01(0.49%)

Last update at 2026-06-12T06:10:00Z

Day Range

2.022.06
LowHigh

52 Week Range

1.912.99
LowHigh

Fundamentals

  • Previous Close 2.03
  • Market Cap749.86M
  • Volume1888996
  • P/E Ratio50.25
  • Dividend Yield3.66%
  • EBITDA106.72M
  • Revenue TTM767.82M
  • Revenue Per Share TTM2.08
  • Gross Profit TTM 241.84M
  • Diluted EPS TTM0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 11.65M -57.07500M 30.63M 22.56M 45.22M
Minority interest -0.14600M - - - -
Net income 4.67M -60.69900M 25.04M 14.60M 31.27M
Selling general administrative 418.16M 305.80M 285.58M 227.00M 207.56M
Selling and marketing expenses - 243.91M - - -
Gross profit 599.09M 446.78M 419.06M 339.52M 331.79M
Reconciled depreciation 56.53M 46.86M 43.49M 36.70M 34.91M
Ebit 31.16M -34.76200M 49.00M 33.04M 54.13M
Ebitda 87.70M 12.10M 92.48M 69.74M 89.04M
Depreciation and amortization 56.53M 46.86M 43.49M 36.70M 34.91M
Non operating income net other - - - - -
Operating income 57.53M 42.17M 39.83M 38.62M 49.37M
Other operating expenses 569.68M 359.96M 201.74M 149.74M 146.66M
Interest expense 28.77M 22.31M 18.36M 10.48M 8.91M
Tax provision 6.84M 3.56M 5.59M 7.96M 13.95M
Interest income 1.09M 0.86M 18.20M 0.04M 0.09M
Net interest income -27.81400M -21.68600M -17.94200M -10.44400M -8.82100M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 6.84M 3.56M 5.59M 7.96M 13.95M
Total revenue 627.22M 469.70M 440.10M 358.74M 348.81M
Total operating expenses 541.55M 404.61M 379.92M 303.09M 277.61M
Cost of revenue 28.13M 22.92M 21.04M 19.22M 17.02M
Total other income expense net -45.87900M -99.24300M 9.44M -3.42700M -0.13400M
Discontinued operations - - - - -
Net income from continuing ops 4.82M -60.69900M 25.04M 14.60M 31.27M
Net income applicable to common shares 4.67M -60.69900M 25.04M 14.60M 31.27M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 1426.47M 744.28M 839.01M 783.01M 654.90M
Intangible assets 59.88M - 30.30M 28.02M 28.94M
Earning assets - - - - -
Other current assets 4.08M 3.56M 2.47M 1.70M 2.25M
Total liab 732.53M 442.57M 465.96M 435.77M 400.16M
Total stockholder equity 693.00M 301.71M 373.05M 347.24M 254.74M
Deferred long term liab - - - - -
Other current liab 8.45M 59.34M 7.48M 16.38M 15.86M
Common stock - 335.00M 333.28M 322.54M 219.22M
Capital stock 735.40M - 333.28M 322.54M 219.22M
Retained earnings -37.13500M -24.96500M 49.56M 37.16M 44.40M
Other liab - - 34.89M 31.99M 30.88M
Good will 802.50M 373.34M 444.48M 352.46M 315.79M
Other assets - 0.00000M 19.03M 17.25M 16.34M
Cash 52.10M 42.44M 33.85M 123.19M 62.20M
Cash and equivalents - - - - -
Total current liabilities 140.66M 87.15M 82.67M 80.00M 77.90M
Current deferred revenue - 1.46M 48.11M 37.72M 40.31M
Net debt 289.15M 315.36M 331.22M 217.80M 246.15M
Short term debt - 16.17M 16.67M 17.21M 16.97M
Short long term debt - - 2.45M 5.47M 6.54M
Short long term debt total - 357.80M 365.08M 340.99M 308.35M
Other stockholder equity - - -382.83600M -359.69900M -263.62200M
Property plant equipment - - 282.46M 231.13M 211.49M
Total current assets 95.28M 74.82M 62.74M 153.98M 82.25M
Long term investments 0.00500M - 0.01M 0.16M 0.10M
Net tangible assets - - -101.72400M -33.24300M -89.99000M
Short term investments - - 0.38M 0.38M 0.34M
Net receivables 30.08M 27.18M 21.69M 19.41M 14.26M
Long term debt 341.25M - 221.14M 217.58M 192.19M
Inventory 2.52M 1.65M 1.85M 1.26M 0.91M
Accounts payable 20.59M 10.18M 10.41M 8.69M 4.75M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -8.32900M -9.78800M -12.45500M -8.88300M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 25.73M - - -
Deferred long term asset charges - - - - -
Non current assets total 1331.19M 669.46M 776.27M 629.03M 572.65M
Capital lease obligations 243.75M - 141.48M 117.94M 109.63M
Long term debt total - - 348.41M 323.78M 291.38M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -64.99400M -27.90300M -128.95800M -55.69300M -56.66300M
Change to liabilities - - 1.40M -0.21300M -1.13700M
Total cashflows from investing activities -64.99400M -27.90300M -128.95800M -55.69300M -56.66300M
Net borrowings 35.11M -2.42400M -21.41200M 13.04M 8.40M
Total cash from financing activities 0.71M -29.45400M -31.84900M 81.13M -7.83400M
Change to operating activities - - 5.55M 0.70M 6.57M
Net income 4.67M -60.69900M 25.04M 14.60M 31.27M
Change in cash 9.67M 8.58M -89.33800M 60.99M 4.24M
Begin period cash flow 42.44M 33.85M 123.19M 62.20M 57.97M
End period cash flow 52.10M 42.44M 33.85M 123.19M 62.20M
Total cash from operating activities 73.77M 66.16M 71.42M 37.10M 69.57M
Issuance of capital stock - 1.72M 2.20M 91.83M 1.79M
Depreciation - 47.10M 43.49M 36.70M 34.91M
Other cashflows from investing activities 0.31M -4.02500M -84.96300M -27.92300M -36.40400M
Dividends paid -15.45700M -13.82200M -12.64000M -20.86300M -17.88600M
Change to inventory -2.41100M -0.46600M - - -
Change to account receivables -0.02800M -3.25000M -0.35200M -3.43600M -2.91800M
Sale purchase of stock -0.56300M 1.72M 43.05M 114.15M -0.13900M
Other cashflows from financing activities -18.94300M -14.92900M -19.25200M -14.15500M 25.18M
Change to netincome - - -9.44700M -2.46000M 1.25M
Capital expenditures 59.76M 23.88M 43.99M 27.77M 20.27M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 12.03M 3.98M -0.35200M -3.43600M -2.91800M
Stock based compensation - 1.59M 2.54M -1.20843M 2.08M
Other non cash items 61.75M 74.20M 2.89M -14.20200M 3.39M
Free cash flow 14.01M 42.28M 27.42M 9.33M 49.30M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IDX
Integral Diagnostics Ltd		 0.01 0.49% 2.04 50.25 13.40 0.98 1.11 1.72 10.99
SHL
Sonic Healthcare Ltd		 -0.08 0.39% 20.20 18.27 14.47 0.96 1.14 1.46 8.61
ACL
Australian Clinical Labs Ltd		 - -% 2.16 15.43 12.00 0.55 2.69 0.95 3.88
PEB
Pacific Edge Ltd		 0.01 4.00% 0.26 - - 22.52 33.42 30.52 -7.8581
MVF
Monash Ivf Group Ltd		 0.01 2.24% 0.69 17.13 13.42 0.99 1.05 1.69 8.96

Reports Covered

Stock Research & News

View All

Profile

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. Integral Diagnostics Limited was founded in 1967 and is headquartered in Melbourne, Australia.

Integral Diagnostics Ltd

45 William Street, Melbourne, VIC, Australia, 3000

Key Executives

Name Title Year Born
Dr. Ian Kadish M.B.A., MBBCh, MBA CEO, MD & Director 1963
Mr. Craig White Chief Financial Officer NA
Mr. Paul McCrow Chief Operating Officer NA
Dr. Jacqueline Milne MBBS Exec. Director NA
Dr. Nazar Bokani M.D. Non-Independent Exec. Director NA
Mr. Julian Gully Chief Information Officer NA
Ms. Mica Duncalfe Chief People Officer NA
Dr. Lisa Sorger MBBS Chief Medical Officer NA
Ms. Kirsty Lally B.Com., C.A. Company Sec. NA
Dr. Ian Kadish M.B.A., MBBCh CEO, MD & Director 1963

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.